ReNew Secures $95 Million Equity Investment From LeapFrog-Led Consortium to Expand its Commercial & Industrial Platform March 16, 2026 LeapFrog leads with $50 million, joined by co‑investors Emerging Market Climate Action Fund (“EMCAF”) and Carlyle AlpInvest ReNew has one of the largest clean energy portfolios for corporate customers in India
Labour told to scrap ‘arbitrary’ inheritance tax system March 15, 2026 The UK government is being urged to scrap the inheritance tax system following warnings that that it enforces the UK as a “high-tax outlier” and risks stifling investment and driving entrepreneurs abroad. A new report from the Institute of Economic Affairs (IEA) highlights that nearly half of the 38 OECD countries – where members are [...]
Miliband and Reeves to meet petrol retailers as fuel costs spike March 13, 2026 Energy Secretary Ed Miliband has said the government “will not tolerate” energy firms profiteering from the rising price of oil amid the war in Iran. Oil prices climbed back above $100 a barrel on Thursday despite the International Energy Agency (IEA) saying on Wednesday that it would release a record 400 million barrels of oil [...]
Richmond council to consider Lime’s future in contract vote March 12, 2026 Richmond councillors will next week decide whether to force Lime out of the borough’s booming e-bike market, City AM understands, as riders are mobilised ahead of a crunch committee meeting that could reshape cycling across southwest London. Emails seen by City AM show Lime users have been invited to attend Monday evening’s transport and air [...]
Here comes Elon: Tesla wins licence to supply electricity in Britain March 12, 2026 Tesla has been granted approval to supply electricity to homes and businesses across the UK, opening the door for the electric vehicle giant to enter the country’s retail energy market. Energy regulator Ofgem confirmed on Thursday that Tesla Energy Ventures Limited, a subsidiary of Musk’s company, has been granted an electricity supply licence by the [...]
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan March 11, 2026 Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually.
Land development transparency plans ‘solve problem that doesn’t exist’ March 10, 2026 The government has been accused of offering a solution to “a problem that doesn’t exist” over an initiative requiring landowners to publicly declare options over land. The new policy, set to be unveiled by planning minister Matthew Pennycook on Monday, is intended to help small and medium-sized (SME) housebuilders by boosting transparency. The government hopes [...]
How geopolitics is influencing investment March 6, 2026 The UK’s classification of AI as critical infrastructure is being paradoxically balanced by increasingly strict national security scrutiny on ownership, investment, and partnerships, introducing political risk into the innovation pipeline, says Claire Trachet Britain classified AI as critical national infrastructure last September, sitting it alongside defence, energy and telecommunications. At Davos this year, former UK [...]
Algoma Central Corporation Reports Financial Results for Fiscal 2025 March 5, 2026 Strong momentum continues in 2025 through resilient performance and strategic fleet growth across global and domestic markets
Taylor Wimpey profit halves as Budget impacts sales March 5, 2026 The UK’s third-largest house builder saw its profits halve last year due to the cost of fire safety regulations and a regulatory settlement with the competition watchdog. Taylor Wimpey’s profit plummeted by 54 per cent to £146.5m despite revenue growing by 13 per cent to £3.8bn, in the financial year to December 2025. The group [...]